We are live on ! Find out more
SSC

Syverson Strege & Co Portfolio holdings

AUM $459M
1-Year Est. Return 27.74%
This Fund
S&P 500
This Quarter Est. Return
-3.62%
1 Year Est. Return
+27.74%
3 Year Est. Return
+66.84%
5 Year Est. Return
+69.83%
10 Year Est. Return
AUM
$92M
AUM Growth
-$43M
Cap. Flow
-$39.3M
Cap. Flow %
-42.69%
Top 10 Hldgs %
57.91%
Holding
342
New
29
Increased
103
Reduced
25
Closed
30
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONL
326
Orion Office REIT
ONL
$170M
-242
Closed -$5K
RIG icon
327
Transocean
RIG
$5.81B
$0 ﹤0.01%
69
RIVN icon
328
Rivian
RIVN
$23B
-71
Closed -$7K
RMD icon
329
ResMed
RMD
$31B
-27
Closed -$7K
RMR icon
330
The RMR Group
RMR
$331M
$0 ﹤0.01%
6
RYAM icon
331
Rayonier Advanced Materials
RYAM
$626M
$0 ﹤0.01%
42
SDIV icon
332
Global X SuperDividend ETF
SDIV
$1.21B
-50
Closed -$2K
SONY icon
333
Sony
SONY
$138B
$0 ﹤0.01%
5
TDOC icon
334
Teladoc Health
TDOC
$1.3B
-40
Closed -$4K
UTF icon
335
Cohen & Steers Infrastructure Fund
UTF
$3.05B
-960
Closed -$27K
LUMO
336
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$0 ﹤0.01%
22
IMGN
337
DELISTED
Immunogen Inc
IMGN
$0 ﹤0.01%
42
ALR
338
DELISTED
AlerisLife Inc
ALR
$0 ﹤0.01%
48
GWB
339
DELISTED
Great Western Bancorp, Inc.
GWB
-313
Closed -$11K
RDS.A
340
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
-1,541
Closed -$67K
MFGP
341
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$0 ﹤0.01%
8
CTIC
342
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$0 ﹤0.01%
3

Similar funds

Syverson Strege & Co's Q1 2022 Portfolio in Review

As of Q1 2022, Syverson Strege & Co held 342 positions worth $92M, down 32% from $135M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Syverson Strege & Co withdrew a net $39.3M in Q1 2022, closing 30 positions and reducing 25 holdings. Its most notable exit was Dimensional US Core Equity 2 ETF, an estimated $20.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 3.8% of assets, up from 2.5% a quarter earlier, followed by Industrials and Technology.

Against the trend, Syverson Strege & Co opened a new position in NEOS Nasdaq-100 Hedged Equity Income ETF worth $109K.

  • Syverson Strege & Co's largest Q1 2022 buy was NEOS Nasdaq-100 Hedged Equity Income ETF: 2,224 shares worth $109K.
  • Syverson Strege & Co added most to iShares Core 80/20 Aggressive Allocation ETF in Q1 2022, an estimated $173K increase.
  • Syverson Strege & Co's biggest Q1 2022 reduction was BlackRock Short Maturity Municipal Bond ETF, cutting an estimated $4.67M.
  • Syverson Strege & Co fully exited Dimensional US Core Equity 2 ETF in Q1 2022, selling an estimated $20.2M.
  • Syverson Strege & Co's ten largest holdings make up 58% of its $92M portfolio in Q1 2022.
  • Syverson Strege & Co opened 29 new positions and closed 30 in Q1 2022.
  • Syverson Strege & Co's portfolio value fell 32% quarter-over-quarter to $92M.

Based on Syverson Strege & Co's 13F filing for Q1 2022, filed 13 Apr 2022.